Scotland Clears New Bladder Cancer Combination Therapy

Published Date: 13 May 2026

The Scottish Medicines Consortium has approved a new first-line combination therapy for restricted use in adults with unresectable or metastatic urothelial cancer.

Read Full News

Latest News

IM Naloxone Improves Prehospital Opioid Overdose Outcomes

Intramuscular naloxone is linked to better prehospital outcomes, including faster recovery and fewer repeat doses, than intranasal naloxone in patients with suspected opioid overdose, a study finds.

Oxygen Titration Protocol Cuts Severe Hyperoxemia in the ED

An emergency department oxygen titration protocol reduces severe hyperoxemia in mechanically ventilated patients but increases moderate hypoxemia, a study finds.

Feeding Difficulties in Kids Increase Hospital Use and Costs

The presence of feeding difficulties was directly linked to longer hospital stays and higher costs, regardless of other factors.

US Recreational, Unintentional Marijuana Use Surges

Both recreational use and unintentional exposure to marijuana in the US rose significantly from 2015 to 2021, especially in children and adolescents, new survey data show.

ED Overcrowding Linked to Near-Tenfold Rise in Deaths

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe Faces Growing Synthetic Opioids Risks as Drug Market Evolves, EU Agency Warns

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Latest News

Intramuscular naloxone is linked to better prehospital outcomes, including faster recovery and fewer repeat doses, than intranasal naloxone in patients with suspected opioid overdose, a study finds.

An emergency department oxygen titration protocol reduces severe hyperoxemia in mechanically ventilated patients but increases moderate hypoxemia, a study finds.

The presence of feeding difficulties was directly linked to longer hospital stays and higher costs, regardless of other factors.

Both recreational use and unintentional exposure to marijuana in the US rose significantly from 2015 to 2021, especially in children and adolescents, new survey data show.

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

News All Time

Australian Doctors Lukewarm on Latest Federal Budget

Australia's latest federal budget includes $25 billion extra for public hospitals but offers little new support for general practitioners and rural healthcare.

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Ebola Deaths in Eastern Congo Rise to 131, WHO Voices Deep Concern

Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health...

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Pediatric eye injuries related to use of cosmetics rose 5.6% from 2020 to 2024, with toddlers most commonly affected and teens showing the largest increases, a new study finds.

Can Rise of Direct Primary Care Ease Hospital Admissions?

Research has shown direct care may reduce emergency department visit and hospital use, but questions remain about equity.

AI Beats Physicians AVSs for Hospital Patients

AI over docs: AI-generated after-visit summaries are better than physician-generated ones, physician graders say. Next, patients will judge.

Hydronephrosis on USG Predicts Stones but May Not Cut CT Use

Hydronephrosis identified on point-of-care ultrasound is linked to higher risks for stone disease and early urologic intervention in suspected renal colic but not with reduced CT use or ED stays.

US Kratom Use Surges 65-Fold in 13 Years

US Kratom use increased more than 65-fold from 2010 to 2023, with a lower incidence of adverse outcomes in states that banned the substance, new research shows.

Apnimed's Sleep Apnea Pill Meets Main Goal in Late-stage Study

Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main ⁠goal in a late-stage trial, potentially offering a convenient...

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

African Public Health Agency Announces New Ebola Outbreak in Congo, 65 Suspected Deaths

Africa's top public health agency said on Friday that there was a confirmed Ebola outbreak in Democratic Republic of Congo's Ituri province, with 65 deaths out of 246...

Recommended News For You

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

Getting More Done With Less Blood.

A study on lung cancer provides additional proof of the value of screening.

Trump slashed US cancer research by 31 percent: Senate report

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

O. A. J. Simpson passes away from cancer.

Recommended Articles For You

Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength 

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients 

From Bruises to Blood Clots: Everything You Need to Know about Hematoma  

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

2.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

3.

Millions of men could benefit from faster scan to diagnose prostate cancer

4.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

5.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

1.

Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends

2.

A Closer Look at the Effects of Sickle Cell on Eyesight

3.

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection

4.

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care

5.

Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

3.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

4.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

5.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot